Results 61 to 70 of about 2,408 (165)

Neoadjuvant Avelumab Plus Axitinib Enabling Curative Resection of Renal Cell Carcinoma With Direct Liver Invasion: A Case Report

IJU Case Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Introduction Direct liver invasion by renal cell carcinoma (RCC) is rare and often precludes margin‐negative resection. Herein, we report a case where neoadjuvant treatment with avelumab plus axitinib downstaged the disease, enabling complete surgical resection. Case Presentation A 67‐year‐old woman presented with gross hematuria.
Fumihiro Ito, Koki Kobayashi, Gaku Hayashi, Shunsuke Kamijo, Takashi Fujita   +4 more
wiley   +1 more source

Clinical and Pathological Complete Remission in a Patient With Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: Is mRCC Curable With Targeted Therapy?

Urology Case Reports, 2015
We report a patient with metastatic clear-cell renal cell carcinoma (mRCC) who presented with primary tumor in situ in the left kidney and metastases to bone, liver, lungs, and brain.
Amishi Y. Shah, Jose A. Karam, Zita D. Lim, Chaan S. Ng, Nizar M. Tannir   +4 more
doaj   +1 more source

PTHrP‐Producing Renal Cell Carcinoma Presenting as Rapidly Progressive Cognitive Impairment: A Case Report

IJU Case Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Introduction Humoral hypercalcemia of malignancy (HCM) caused by parathyroid hormone–related peptide (PTHrP) is a common paraneoplastic syndrome, and renal cell carcinoma (RCC) is one of the main causes. However, initial presentation with rapidly progressive cognitive decline is rare.
Fumiakira Yano, Norifumi Sawada, Norikazu Tanaka, Koshiro Hikawa, Keiichiro Hirose, Yuko Ohtake, Takahiko Mitsui   +6 more
wiley   +1 more source

Robot-assisted deferred cytoreductive nephrectomy in metastatic renal cell carcinoma following immune checkpoint inhibitors plus tyrosine-kinase inhibitor

Urology Video Journal
Objective: This video aims to demonstrate the safety and feasibility of performing deferred cytoreductive nephrectomy (dCN) using robotic assistance in patient treated with immunotherapy for metastatic renal cell carcinoma (mRCC).
Rocco Simone Flammia, Flavia Proietti, Veronica Palombi, Leslie Claire Licari, Eugenio Bologna, Aldo Brassetti, Giuseppe Simone, Costantino Leonardo   +7 more
doaj   +1 more source

Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach

Frontiers in Oncology, 2017
The past decade has seen a rapid proliferation in the number and types of systemic therapies available for renal cell carcinoma. However, surgery remains an integral component of the therapeutic armamentarium for advanced and metastatic kidney cancer ...
Brian M. Shinder, Kevin Rhee, Douglas Farrell, Nicholas J. Farber, Mark N. Stein, Thomas L. Jang, Eric A. Singer   +6 more
doaj   +1 more source

Abstracts

Molecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Hydroxyurea‐Associated Wunderlich Syndrome in Triple‐Negative Myelofibrosis: A Case Report and Literature Review

Case Reports in Hematology, Volume 2026, Issue 1, 2026.
Background Wunderlich syndrome (WS) is a spontaneous, nontraumatic intrarenal or perirenal hemorrhage most commonly related to renal neoplasms, vascular disorders, infection, cyst rupture, or anticoagulation. Clinical severity ranges from self‐limited bleeding to hemorrhagic shock.
Veysel Erol, Zeki Güzel, İbrahim Ethem Akgün, Gökhan Ecer, Rounak Dubey   +4 more
wiley   +1 more source

Management of Renal Cell Carcinoma- Current Practice in Sub-Saharan Africa

Journal of Kidney Cancer and VHL, 2019
There is a global variation in the incidence of renal masses with the developed nations having a greater incidence. About 80–90% of renal malignancies are renal cell carcinomas (RCC) which account for 2–4% of all cancers.
Ayun Kotokai Cassell, Mohamed Jalloh, Bashir Yunusa, Medina Ndoye, Mouhamadou Mbodji, Abdourahmane Diallo, Saint Charles Kouka, Issa Labou, Lamine Niang, Serigne M. Gueye   +9 more
doaj   +1 more source

Case Report: Locally advanced clear cell renal cell carcinoma with pathological complete response following nephrectomy and thrombectomy after nivolumab and cabozantinib treatment

Frontiers in Oncology
The recent introduction of systemic anticancer therapies (SACT) and immune checkpoint inhibitors in cancer management has led to reports on the usefulness of deferred cytoreductive nephrectomy (dCN) following vascular endothelial growth factor receptor ...
Hayato Yoshioka, Hiroyuki Kitano, Kohei Kobatake, Yohei Sekino, Akira Ishikawa, Keisuke Goto, Akihiro Goriki, Keisuke Hieda, Kouji Arihiro, Nobuyuki Hinata   +9 more
doaj   +1 more source

Severe Dyspnea due to Pulmonary Metastasis of Renal Cell Carcinoma: Is Cytoreductive Surgery of Value

Case Reports in Oncology, 2010
Here, we present a case in which cytoreductive surgery, like left radical nephrectomy, was effective in the treatment of pulmonary metastases and para-aortic metastases from renal cell carcinoma.
Mohammad Kazem Moslemi, Seiied Jalal Esshagh Hosseini, Seiied Mohammad Amin Joorabchin   +2 more
doaj   +1 more source